Cargando…

Transient dermatomyositis-like reaction following COVID-19 messenger RNA vaccination

Detalles Bibliográficos
Autores principales:	Gutierrez, Rodrigo A., Connolly, Kari, Gross, Andrew, Haemel, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288173/ https://www.ncbi.nlm.nih.gov/pubmed/37366492 http://dx.doi.org/10.1016/j.jdcr.2023.05.028

Ejemplares similares

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
por: Drohan, Alex, et al.
Publicado: (2021)

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case Series
por: Peigottu, Maria Francesca, et al.
Publicado: (2021)

Preserved recognition of Omicron spike following COVID-19 messenger RNA vaccination in pregnancy
por: Bartsch, Yannic C., et al.
Publicado: (2022)

Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
por: Gouda, Wesam, et al.
Publicado: (2022)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
por: Chopra, Shara, et al.
Publicado: (2021)

Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction
por: Eastman, Jacqueline, et al.
Publicado: (2022)

Systemic Lupus Induced by Messenger RNA Vaccination
por: Voisin, Olivier, et al.
Publicado: (2022)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Disseminated varicella-zoster virus infections following messenger RNA–based COVID-19 vaccination
por: Said, Jordan Taylor, et al.
Publicado: (2021)

Myocarditis Following a COVID-19 Messenger RNA Vaccination: A Japanese Case Series
por: Murakami, Yoshiki, et al.
Publicado: (2021)

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
por: Le Vu, Stéphane, et al.
Publicado: (2022)

This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
por: Kantor, Jonathan
Publicado: (2022)

Disease flare in patients with dermatomyositis following COVID-19 vaccination
por: Pan, Catherina X., et al.
Publicado: (2022)

Cicatricial conjunctivitis secondary to discoid lupus erythematosus
por: Chen, Shelley, et al.
Publicado: (2020)

COVID-19 vaccine: Vaccine reaction, amyopathic dermatomyositis and interstitial lung disease: case report
Publicado: (2021)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Allergy evaluation of messenger RNA vaccine reactions is crucial, with a specific role for polyethylene glycol testing
por: Shrestha, Pragya, et al.
Publicado: (2022)

Acute generalized exanthematous pustulosis induced by Moderna COVID-19 messenger RNA vaccine
por: Agaronov, Anna, et al.
Publicado: (2021)

Pityriasis lichenoides chronica induced by COVID-19 messenger RNA vaccination
por: Al Muqrin, Abdullah M., et al.
Publicado: (2022)

Eczematous reaction to IVIG for the treatment of dermatomyositis()()
por: Berk-Krauss, J., et al.
Publicado: (2018)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

The new generation of messenger RNA (mRNA) vaccines against influenza
por: Reina, Jordi
Publicado: (2023)

qPCR multiplex detection of microRNA and messenger RNA in a single reaction
por: Khoury, Samantha, et al.
Publicado: (2020)

COVID-19 vaccine-associated dermatomyositis
por: Wu, Marlyn, et al.
Publicado: (2022)

Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence?
por: A. Rashid, Mohd Radzniwan, et al.
Publicado: (2022)

A thermostable messenger RNA based vaccine against rabies
por: Stitz, Lothar, et al.
Publicado: (2017)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype
por: Pascolo, Steve
Publicado: (2021)

Acute interstitial nephritis after messenger RNA-based vaccination
por: Czerlau, Cecilia, et al.
Publicado: (2021)

Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
por: Huff, Amanda L., et al.
Publicado: (2022)

Pityriasis rosea–like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature
por: Buckley, Jordan E., et al.
Publicado: (2022)

Dermatomyositis following COVID-19 infection
por: Derbel, A., et al.
Publicado: (2021)

Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine
por: Irvine, Nathaniel J, et al.
Publicado: (2021)

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
por: St. Clair, Benjamin D., et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine
por: Wang, Mingwei, et al.
Publicado: (2022)

Pityriasis rubra pilaris potentially triggered by messenger RNA–1273 COVID vaccine
por: Ajebo, Etsubdenk M., et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Purtscher-like retinopathy associated with dermatomyositis
por: Yan, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3pkcei9a5vgtq1836ubbce6d8f